JP Morgan Chase
PRPH

JP Morgan Chase’s ProPhase Labs PRPH Stock Holding History

JP Morgan Chase’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-177
Closed -$79 – 7810
2025
Q4 		$79 Hold
177
– – ﹤0.01% 7231
2025
Q3 		$808 Hold
177
– – ﹤0.01% 7003
2025
Q2 		$691 Sell
177
-3
-2% -$10 ﹤0.01% 6662
2025
Q1 		$727 Hold
180
– – ﹤0.01% 6664
2024
Q4 		$1.36K Hold
180
– – ﹤0.01% 6691
2024
Q3 		$4.36K Buy
+180
New +$5.07K ﹤0.01% 6515
2021
Q4 		– Sell
-573
Closed -$30K – 6896
2021
Q3 		$30K Buy
+573
New +$34.1K ﹤0.01% 5967
2021
Q2 		– Hold
0
– – – 6560
2021
Q1 		– Hold
0
– – – 6283
2016
Q1 		– Sell
-35
Closed -$1K – 4883
2015
Q4 		$1K Buy
+35
New +$507 ﹤0.01% 4609

Other funds holding PRPH

CA
CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

JP Morgan Chase's PRPH Position: Q1 2026 in Review

JP Morgan Chase sold out of ProPhase Labs (PRPH) in Q1 2026, closing a stake of 177 shares — an estimated $79 sold.

JP Morgan Chase first reported a position in PRPH in Q4 2015 and held it in 8 quarters. The position peaked at $30K in Q3 2021. 2 funds tracked by Wall St. Rank hold PRPH as of Q1 2026.

  • JP Morgan Chase reported no remaining ProPhase Labs position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 177 ProPhase Labs shares in Q1 2026, an estimated $79.
  • JP Morgan Chase first reported a position in ProPhase Labs in Q4 2015 and held it in 8 quarters.
  • JP Morgan Chase's ProPhase Labs position peaked at $30K in Q3 2021.
  • 2 funds tracked by Wall St. Rank held ProPhase Labs as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.